Myriad Genetics
MYGN
MYGN
233 hedge funds and large institutions have $1.61B invested in Myriad Genetics in 2017 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 96 increasing their positions, 57 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5.1% more ownership
Funds ownership: 117.94% → 123.04% (+5.1%)
4% more funds holding
Funds holding: 223 → 233 (+10)
59% less call options, than puts
Call options by funds: $3.62M | Put options by funds: $8.89M
Holders
233
Holding in Top 10
3
Calls
$3.62M
Puts
$8.89M
Top Buyers
| 1 | +$183M | |
| 2 | +$27.4M | |
| 3 | +$19M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.2M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$12.4M |
Top Sellers
| 1 | -$41.3M | |
| 2 | -$20.7M | |
| 3 | -$19.2M | |
| 4 |
AIM
Assured Investment Management
New York
|
-$16.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$16.2M |